These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18520325)

  • 1. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia.
    Berjohn CM; Fishman NO; Joffe MM; Edelstein PH; Metlay JP
    Medicine (Baltimore); 2008 May; 87(3):160-166. PubMed ID: 18520325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
    Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
    Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
    Chokshi R; Restrepo MI; Weeratunge N; Frei CR; Anzueto A; Mortensen EM
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):447-51. PubMed ID: 17534677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.
    Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J;
    Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.
    Viasus D; Simonetti AF; Garcia-Vidal C; Niubó J; Dorca J; Carratalà J
    J Antimicrob Chemother; 2017 Feb; 72(2):547-553. PubMed ID: 27798219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.
    Moroney JF; Fiore AE; Harrison LH; Patterson JE; Farley MM; Jorgensen JH; Phelan M; Facklam RR; Cetron MS; Breiman RF; Kolczak M; Schuchat A
    Clin Infect Dis; 2001 Sep; 33(6):797-805. PubMed ID: 11512085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic de-escalation therapy in patients with community-acquired nonbacteremic pneumococcal pneumonia.
    Uda A; Tokimatsu I; Koike C; Osawa K; Shigemura K; Kimura T; Miyara T; Yano I
    Int J Clin Pharm; 2019 Dec; 41(6):1611-1617. PubMed ID: 31654366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.
    Cilloniz C; Albert RK; Liapikou A; Gabarrus A; Rangel E; Bello S; Marco F; Mensa J; Torres A
    Am J Respir Crit Care Med; 2015 Jun; 191(11):1265-72. PubMed ID: 25807239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.
    Martínez JA; Horcajada JP; Almela M; Marco F; Soriano A; García E; Marco MA; Torres A; Mensa J
    Clin Infect Dis; 2003 Feb; 36(4):389-95. PubMed ID: 12567294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.
    Waterer GW; Somes GW; Wunderink RG
    Arch Intern Med; 2001 Aug 13-27; 161(15):1837-42. PubMed ID: 11493124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.
    Ruiz LA; España PP; Gómez A; Bilbao A; Jaca C; Arámburu A; Capelastegui A; Restrepo MI; Zalacain R
    BMC Geriatr; 2017 Jun; 17(1):130. PubMed ID: 28633626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe pneumococcal pneumonia: new strategies for management.
    Chiou CC; Yu VL
    Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.
    Brandenburg JA; Marrie TJ; Coley CM; Singer DE; Obrosky DS; Kapoor WN; Fine MJ
    J Gen Intern Med; 2000 Sep; 15(9):638-46. PubMed ID: 11029678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal antibiotic treatment in severe pneumococcal pneumonia--time for real answers.
    Waterer GW
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):691-2. PubMed ID: 16244854
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis.
    De la Calle C; Ternavasio-de la Vega HG; Morata L; Marco F; Cardozo C; García-Vidal C; Del Rio A; Cilloniz C; Torres A; Martínez JA; Mensa J; Soriano A
    J Infect; 2018 Apr; 76(4):342-347. PubMed ID: 29360520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
    Plouffe JF; Martin DR
    Infect Dis Clin North Am; 2004 Dec; 18(4):963-74; x-xi. PubMed ID: 15555834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.